A delayed diagnosis of panhypopituitarism presented with osteoporosis

References (11)

1. Yassin AA, Nettleship JE, Almehmadi Y, Yassin DJ, El Douaihy Y, Saad F. Is there a relationship between the severity of erectile dysfunction and the comorbidity profile in men with late onset hypogonadism? Arab J Urol. 2015;13:162-8
2. Biller BM, Samuels MH, Zagar A, Cook DM, Arafah BM, Bonert V et al: Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency. J Clin Endocrinol Metab. 2002;87:2067-79
3. Consensus guidelines for the diagnosis and treatment of adults with GH deficiency. Summary statement of the GH Research Society Workshop on Adult GH Deficiency. J Clin Endocrinol Metab. 1998 83:379-81
4. Karaca Z, Ayhan L, Tanrıverdi F, Kula M, Unluhizarci K, Kelestimur F. The comparison of low and standard dose ACTH and glucagon stimulation tests in the evaluation of hypothalamic-pituitary-adrenal axis in healthy adults. Pituitary. 2011;14:134-40
5. Snyder PJ, Peachey H, Hannoush P, Berlin JA, Loh L, Holmes JH et al.Effect of testosterone treatment on bone mineral density in men over 65 years of age. J Clin Endocrinol Metab. 1999;84:1966-72
6. Zitzmann M, Brune M, Vieth V, Nieschlag E. Monitoring bone density in hypogonadal men by quantitative phalangeal ultrasound. Bone. 2002;31:422-9
7. Bhattacharya RK, Bhattacharya SB. Late-onset hypogonadism and testosterone replacement in older men. Clin Geriatr Med. 2015;31:631-44
8. Corona G, Rastrelli G, Vignozzi L, Mannucci E, Maggi M. How to recognize late-onset hypogonadism in men with sexual dysfunction. Asian J Androl. 2012;14:251-9
9. Marinis LD, Bonadonna S, Bianchi A, Maira G, Giustina A. Extensive clinical experience: primary empty sella. J Clin Endocrinol Metab. 2005;90:5471-7
10. Zitzmann M, Brune M, Vieth V, Nieschlag E. Monitoring bone density in hypogonadal men by quantitative phalangeal ultrasound Bone. 2002;31:422-9
11. Wang C, Cunningham G, Does A, Iranmanesh A, Matsumoto AM, Snyder PJ et al. Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men. J Clin Endocrinol Metab. 2004;89:2085-98 12. Wang C, Nieschlag E, Swerdloff R, Behre HM, Hellstrom WJ, Gooren LJ et al. Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations. Eur J Endocrinol. 2008;159:507-14.